OR52A1
gene geneOn this page
Also known as HPFH1OR
Summary
OR52A1 (olfactory receptor family 52 subfamily A member 1, HGNC:8318) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 52A1 (Q9UKL2). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 23538 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- MANE Select transcript:
NM_012375
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8318 |
| Approved symbol | OR52A1 |
| Name | olfactory receptor family 52 subfamily A member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HPFH1OR |
| Ensembl gene | ENSG00000182070 |
| Ensembl biotype | protein_coding |
| Entrez | 23538 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000380367
RefSeq mRNA: 1 — MANE Select: NM_012375
NM_012375
CCDS: CCDS31374
Canonical transcript exons
ENST00000380367 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001484666 | 5146824 | 5152690 |
| ENSE00003813043 | 5154447 | 5154757 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 71.85.
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 71.85 | silver quality |
| parotid gland | UBERON:0001831 | 60.19 | gold quality |
| endothelial cell | CL:0000115 | 55.10 | gold quality |
| upper leg skin | UBERON:0004262 | 53.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 52.39 | gold quality |
| cardia of stomach | UBERON:0001162 | 52.22 | gold quality |
| buccal mucosa cell | CL:0002336 | 49.50 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.45 | gold quality |
| skin of hip | UBERON:0001554 | 48.79 | silver quality |
| ventricular zone | UBERON:0003053 | 46.49 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 44.88 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 44.66 | gold quality |
| sural nerve | UBERON:0015488 | 44.29 | gold quality |
| oocyte | CL:0000023 | 43.86 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 42.15 | gold quality |
| ganglionic eminence | UBERON:0004023 | 41.97 | gold quality |
| bone marrow cell | CL:0002092 | 41.83 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.73 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.68 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 41.59 | silver quality |
| bone marrow | UBERON:0002371 | 41.47 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 41.29 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 41.21 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| ventral tegmental area | UBERON:0002691 | 41.01 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.06 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 52A1 — Q9UKL2 (reviewed: Q9UKL2)
Alternative names: HPFH1OR, Odorant receptor HOR3’beta4, Olfactory receptor OR11-319
All UniProt accessions (1): Q9UKL2
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_036507* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UKL2-F1 | 90.10 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 99–182
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 42 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, PRC2_SUZ12_UP.V1_DN, GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN, GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN
GO Biological Process (5): signal transduction (GO:0007165), sensory perception of smell (GO:0007608), G protein-coupled receptor signaling pathway (GO:0007186), nervous system process (GO:0050877), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): transmembrane signaling receptor activity (GO:0004888), G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| system process | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
182 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR52A1 | C1orf198 | Q9H425 | 571 |
| OR52A1 | INSL5 | Q9Y5Q6 | 506 |
| OR52A1 | TAAR5 | O14804 | 462 |
| OR52A1 | SYNE1 | Q8NF91 | 353 |
| OR52A1 | ZNF280B | Q86YH2 | 351 |
| OR52A1 | HBE1 | P02100 | 350 |
| OR52A1 | PGM3 | O95394 | 339 |
| OR52A1 | CLINT1 | Q14677 | 320 |
| OR52A1 | OR4D6 | Q8NGJ1 | 312 |
| OR52A1 | A0A0J9YYA3 | A0A0J9YYA3 | 309 |
| OR52A1 | ST3GAL4 | Q11206 | 307 |
| OR52A1 | DMXL1 | Q9Y485 | 305 |
| OR52A1 | OR2J1 | Q9GZK6 | 298 |
| OR52A1 | LZIC | Q8WZA0 | 295 |
| OR52A1 | NLRP11 | P59045 | 290 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
206 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5152687:AGACC:A | acceptor_loss | 0.9900 |
| 11:5152688:GACC:G | acceptor_loss | 0.9900 |
| 11:5152689:ACCT:A | acceptor_loss | 0.9900 |
| 11:5152691:C:CC | acceptor_gain | 0.9900 |
| 11:5152691:C:CG | acceptor_loss | 0.9900 |
| 11:5152692:T:A | acceptor_loss | 0.9900 |
| 11:5152686:CAGAC:C | acceptor_gain | 0.9700 |
| 11:5152688:GAC:G | acceptor_gain | 0.9500 |
| 11:5152699:A:T | acceptor_gain | 0.9100 |
| 11:5152698:C:CT | acceptor_gain | 0.9000 |
| 11:5152687:AGAC:A | acceptor_gain | 0.8800 |
| 11:5152689:AC:A | acceptor_gain | 0.8200 |
| 11:5152690:CC:C | acceptor_gain | 0.8200 |
| 11:5153690:T:TA | donor_gain | 0.7500 |
| 11:5153698:T:A | donor_gain | 0.7400 |
| 11:5154640:T:C | donor_gain | 0.7300 |
| 11:5152548:CA:C | donor_gain | 0.7000 |
| 11:5154627:CA:C | donor_gain | 0.7000 |
| 11:5152693:G:GC | acceptor_gain | 0.6800 |
| 11:5154442:CTCA:C | donor_loss | 0.5900 |
| 11:5154443:TCACC:T | donor_loss | 0.5900 |
| 11:5154444:CAC:C | donor_loss | 0.5900 |
| 11:5154445:ACCA:A | donor_loss | 0.5900 |
| 11:5154446:C:CA | donor_loss | 0.5900 |
| 11:5152638:A:AC | donor_gain | 0.5800 |
| 11:5154438:ATCAC:A | donor_loss | 0.5800 |
| 11:5154439:TCACT:T | donor_loss | 0.5800 |
| 11:5153687:A:AC | donor_gain | 0.5600 |
| 11:5153688:C:CC | donor_gain | 0.5600 |
| 11:5154739:C:CC | acceptor_gain | 0.5500 |
AlphaMissense
2069 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5152136:G:C | S78R | 0.887 |
| 11:5152136:G:T | S78R | 0.887 |
| 11:5152138:T:G | S78R | 0.887 |
| 11:5152139:G:C | S77R | 0.873 |
| 11:5152139:G:T | S77R | 0.873 |
| 11:5152141:T:G | S77R | 0.873 |
| 11:5151569:A:C | F267L | 0.849 |
| 11:5151569:A:T | F267L | 0.849 |
| 11:5151571:A:G | F267L | 0.849 |
| 11:5151527:G:C | S281R | 0.847 |
| 11:5151527:G:T | S281R | 0.847 |
| 11:5151529:T:G | S281R | 0.847 |
| 11:5151608:G:C | F254L | 0.808 |
| 11:5151608:G:T | F254L | 0.808 |
| 11:5151610:A:G | F254L | 0.808 |
| 11:5151584:G:C | F262L | 0.802 |
| 11:5151584:G:T | F262L | 0.802 |
| 11:5151586:A:G | F262L | 0.802 |
| 11:5151699:A:T | I224K | 0.778 |
| 11:5152271:G:C | F33L | 0.771 |
| 11:5152271:G:T | F33L | 0.771 |
| 11:5152273:A:G | F33L | 0.771 |
| 11:5151911:C:A | R153S | 0.770 |
| 11:5151911:C:G | R153S | 0.770 |
| 11:5151699:A:G | I224T | 0.768 |
| 11:5152010:C:A | M120I | 0.765 |
| 11:5152010:C:G | M120I | 0.765 |
| 11:5152010:C:T | M120I | 0.765 |
| 11:5151731:G:C | D213E | 0.764 |
| 11:5151731:G:T | D213E | 0.764 |
dbSNP variants (sampled 300 via entrez): RS1000245039 (11:5152008 G>A,T), RS1000356911 (11:5154550 T>C), RS1000482415 (11:5147902 C>T), RS1000497123 (11:5153801 C>A,T), RS1000514634 (11:5147640 T>C), RS1000956105 (11:5156554 C>G,T), RS1001009764 (11:5156350 G>A), RS1001514678 (11:5153748 C>CT), RS1001967010 (11:5153356 A>C), RS1002052345 (11:5147151 A>G), RS1002139286 (11:5147275 T>A,C), RS1002271512 (11:5154502 A>G), RS1003308315 (11:5152467 A>C), RS1003694159 (11:5148818 AAAG>A), RS1003849812 (11:5154322 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases methylation | 2 |
| bisphenol F | affects cotreatment, decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Thiram | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.